Author

Naoya Kitamura

Observed names: Kitamura, Naoya, N Kitamura

Institution: Kao Corporation (Japan)

Observed institutions: Kao Corporation (Japan), Asahi Kasei (Japan), Asahi Kasei Therapeutics Corporation (Japan)

ORCID: 0000-0003-2570-746X

Observed ORCID: 0000-0003-2570-746X

OpenAlex ID: A5103083005

New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey

2017 · Toshiaki Iba, Marcello Di Nisio, et al. · BMJ Open · 449

Postmarketing Surveillance of Recombinant Human Soluble Thrombomodulin (Thrombomodulin α) in Pediatric Patients With Disseminated Intravascular Coagulation

2014 · Akira Shirahata, Jun Mimuro, et al. · Clinical and Applied Thrombosis/Hemostasis · 12

Rosmarinic acid ameliorates HCl-induced cystitis in rats

2023 · Naoya Kitamura, Yasunori Yamamoto, et al. · PLoS ONE · 8

[Long-term (5 to 13 years) evaluation of the Carpentier-Edwards bioprosthesis].

1988 · N Kitamura, C Nojiri, et al. · PubMed

Works count: 5

Citation count: 469

H-index: 3

I10-index: 2